Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FTKPH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,250
Award facts
- Contract value 100% obligated
- $16,249.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $16,249.95 by the Defense Logistics Agency on July 30, 2025, for the supply of Stelara 90 mg/ml syringes. The contract, which carries no set-aside designation, is scheduled for ultimate completion by August 20, 2025, with performance taking place at the contractor's Park Ridge location. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the SPE2DB program, a $499.999 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
Stelara, a biologic medication used primarily for treating autoimmune conditions, represents one of numerous specialty pharmaceutical products that DMS Pharmaceutical Group supplies to Department of Defense healthcare sites through its established relationship with the Defense Logistics Agency. The contractor has demonstrated consistent success in federal pharmaceutical procurement, leveraging its woman-owned small business status to compete effectively across an extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables. This award reflects the contractor's ongoing role as a critical supplier within the federal pharmaceutical supply chain serving military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FTKPH?
SPE2DB25FTKPH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FTKPH worth?
The government has obligated $16,250 on SPE2DB25FTKPH.
Is contract SPE2DB25FTKPH an order under another contract?
Yes. SPE2DB25FTKPH is a delivery order under SPE2DB22D9112, an indefinite delivery contract.
Was contract SPE2DB25FTKPH competed?
The extent of competition for SPE2DB25FTKPH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award